Rajesh K. Malik

Technik-/Wissenschafts-/F&E-Leiter bei G1 THERAPEUTICS, INC.

Vermögen: 259 824 $ am 30.04.2024

65 Jahre

Health Technology

Consumer Services

Aktive Positionen von Rajesh K. Malik

Unternehmen	Position	Beginn	Ende
G1 THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2014	-
Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	Direktor/Vorstandsmitglied	01.05.2018	-

Unternehmen	Position	Beginn	Ende
POIT BIOP	Direktor/Vorstandsmitglied	30.06.2021	27.12.2023
POIT BIOP	Independent Dir/Board Member	30.06.2021	27.12.2023
AGENNIX AG	Direktor/Vorstandsmitglied	01.01.2007	01.01.2013
AGENNIX AG	Technik-/Wissenschafts-/F&E-Leiter	01.01.2007	01.01.2013
FENNEC PHARMACEUTICALS INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2004	01.01.2007
EMD Pharmaceuticals, Inc. EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.	Direktor/Vorstandsmitglied	01.01.2002	01.01.2004
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01.01.2000	01.01.2002
University of Virginia	Corporate Officer/Principal	-	-
Agennix, Inc. Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2007	-

University of Sheffield Medical School

Doctorate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	4
Director/Board Member	4
Corporate Officer/Principal	2

Sektoral

Health Technology	9
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
FENNEC PHARMACEUTICALS INC.	Health Technology
G1 THERAPEUTICS, INC.	Health Technology
POIT BIOP	Health Technology

Private Unternehmen	4
Agennix, Inc. Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX.	Health Technology
EMD Pharmaceuticals, Inc. EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.	Health Technology
Agennix AG Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany.	Health Technology
Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	Health Technology